rs63750603
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP3_StrongPP5_Strong
The NM_000249.4(MLH1):c.2103G>A(p.Gln701Gln) variant causes a splice region, synonymous change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★★).
Frequency
Consequence
NM_000249.4 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary nonpolyposis colorectal neoplasms Pathogenic:1
This sequence change affects codon 701 of the MLH1 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the MLH1 protein. This variant also falls at the last nucleotide of exon 18 of the MLH1 coding sequence, which is part of the consensus splice site for this exon. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. A different variant affecting this nucleotide (c.2103G>C) has been determined to be pathogenic (PMID: 21404177, 16341550). This suggests that this nucleotide is important for normal RNA splicing, and that other variants at this position may also be pathogenic. This variant is not present in population databases (ExAC no frequency). This variant has been reported in individuals in the Leiden Open-source Variation Database (PMID: 21520333). ClinVar contains an entry for this variant (Variation ID: 90048). Nucleotide substitutions within the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Experimental studies have shown that this variant results in altered mRNA splicing that skips exon 18 (PMID: 26247049). -
Lynch syndrome 1 Uncertain:1
Criteria changed for variants in last base of exon therefore downgrade classification -
Hereditary cancer-predisposing syndrome Uncertain:1
The c.2103G>A variant (also known as p.Q701Q), located in coding exon 18 of the MLH1 gene, results from a G to A substitution at nucleotide position 2103. This nucleotide substitution does not change the at codon 701. However, this change occurs in the last base pair of coding exon 18, which makes it likely to have some effect on normal mRNA splicing. RNA studies have demonstrated that this variant results in an incomplete splice defect resulting in coding exon 18 skipping as well as minor expression of full-length transcripts and transcripts that lack coding exons 17 and 18 (van der Klift HM et al. Mol Genet Genomic Med, 2015 Jul;3:327-45; Ambry internal data). This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice donor site. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at